Skip to main content
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
8.73
-0.64 (-6.83%)
At close: Nov 20, 2024, 4:00 PM
8.90
+0.17 (1.95%)
After-hours: Nov 20, 2024, 7:14 PM EST

Phathom Pharmaceuticals Revenue

Phathom Pharmaceuticals had revenue of $16.35M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $26.27M. In the year 2023, Phathom Pharmaceuticals had annual revenue of $682.00K.

Revenue (ttm)
$26.27M
Revenue Growth
n/a
P/S Ratio
19.86
Revenue / Employee
$58,119
Employees
452
Market Cap
596.93M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023682.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Axogen 180.86M
Standard BioTools 155.90M
Stoke Therapeutics 16.74M
Immunome 10.13M
Dianthus Therapeutics 5.37M
IGM Biosciences 2.92M
Altimmune 52.00K
Revenue Rankings

PHAT News

More News